Medicare Enrolled
Dr. Andrew Marlowe, M.D.
Otology & Neurotology Physician · Sarasota, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Marlowe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marlowe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Marlowe
Dr. Andrew Marlowe is an otology & neurotology physician in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Marlowe performed 3,207 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Marlowe received a total of $10,578 from 40 pharmaceutical and/or device companies across 396 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Marlowe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in FL
$10,578 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 75996 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗3,207
Medicare services
Top 13% in FL for otology & neurotology physician
Not available
Unique patients (not deduplicated)
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,064 | $92 | $218 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
637 | $62 | $150 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
376 | $34 | $98 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
205 | $119 | $333 |
| Flexible laryngoscopy A diagnostic exam of the voice box using a flexible endoscope to visualize the larynx. |
168 | $91 | $246 |
| Nasal endoscopy A diagnostic procedure that uses a thin, lighted tube to examine the inside of the nasal passages. |
118 | $125 | $382 |
| Impacted earwax removal by physician Removal of impacted earwax from one or both ears by a physician on the same day as audiologic testing. |
105 | $38 | $103 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
103 | $73 | $217 |
| Middle ear function test A diagnostic test used to evaluate how well the middle ear is functioning. |
72 | $12 | $32 |
| Comprehensive hearing and speech recognition test A diagnostic evaluation that assesses hearing ability and the capacity to understand spoken words. The test measures how well a patient can detect sounds and recognize speech. |
66 | $27 | $77 |
| CT scan of face, without contrast A computed tomography scan that creates detailed images of the facial structures. This procedure is performed without the use of intravenous contrast dye. |
59 | $97 | $302 |
| Microscopic ear examination A detailed visual inspection of the ear using a specialized microscope to examine the ear canal and eardrum. |
44 | $19 | $57 |
| Eardrum incision with tube insertion A small cut is made in the eardrum to insert a ventilation tube, performed under local or topical anesthesia. |
31 | $160 | $397 |
| Nasal growth removal or destruction This procedure involves the removal or destruction of a growth located in the nose using an approach through the nostrils. |
27 | $566 | $1,834 |
| Endoscopic control of nosebleed A procedure to stop bleeding in the nose using an endoscope to visualize the area. |
27 | $182 | $508 |
| Eardrum incision, aspiration, and/or inflation A procedure involving making an incision in the eardrum, removing fluid, and/or inflating the middle ear space. |
21 | $150 | $374 |
| CT scan of head, without contrast A CT scan uses X-rays to create detailed images of the brain and skull. This specific scan is performed without the use of contrast dye. |
21 | $126 | $354 |
| Removal of foreign body in ear canal | 18 | $51 | $164 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $44 | $91 |
| Simple control of nosebleed A procedure to stop a nosebleed using basic methods. It involves direct pressure or simple packing to control bleeding from the nasal passages. |
14 | $114 | $289 |
| Complex control of nose bleed | 14 | $192 | $458 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,578
Total received (2018-2024)
Avg $1,511/year across 7 years
Top 32% in FL for otology & neurotology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
396
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,025
2023
$1,523
2022
$1,169
2021
$2,690
2020
$907
2019
$1,544
2018
$719
Payments by company (2024)
ABBVIE INC.
$415
GENZYME CORPORATION
$330
PFIZER INC.
$262
Phathom Pharmaceuticals, Inc.
$239
Regeneron Healthcare Solutions, Inc.
$183
GlaxoSmithKline, LLC.
$180
Amgen Inc.
$156
Lilly USA, LLC
$62
SANOFI-AVENTIS U.S. LLC
$55
Lundbeck LLC
$47
Acclarent, Inc
$38
Optinose US, Inc.
$33
Vertical Pharmaceuticals, LLC
$25
Top 3 companies account for 49.8% of 2024 payments
All-time payments by company (2018-2024) ›
Biohaven Pharmaceuticals, Inc.
$1,185
Amgen Inc.
$1,143
ABBVIE INC.
$1,018
GENZYME CORPORATION
$776
Merz North America, Inc.
$681
Teva Pharmaceuticals USA, Inc.
$658
Regeneron Healthcare Solutions, Inc.
$612
PFIZER INC.
$465
Stryker Corporation
$335
Lilly USA, LLC
$323
MED-EL Corporation
$291
AbbVie Inc.
$269
GlaxoSmithKline, LLC.
$239
Phathom Pharmaceuticals, Inc.
$239
Novartis Pharmaceuticals Corporation
$231
Lundbeck LLC
$223
Optinose US, Inc.
$196
Upsher-Smith Laboratories LLC
$193
Biohaven Pharmaceutical Holding Company Ltd.
$168
Advanced Bionics, LLC
$152
SANOFI-AVENTIS U.S. LLC
$137
Kerecis Limited
$137
OptiNose US, Inc.
$108
ALK-Abello, Inc
$101
Medtronic Vascular, Inc.
$100
ARBOR PHARMACEUTICALS, INC.
$100
Acclarent, Inc
$93
Allergan, Inc.
$63
Cochlear Americas
$55
UPSHER-SMITH LABORATORIES LLC
$48
Vertical Pharmaceuticals, LLC
$47
Supernus Pharmaceuticals, Inc.
$41
Hikma Pharmaceuticals USA
$34
Smith & Nephew, Inc.
$21
Merck Sharp & Dohme LLC
$20
Merck Sharp & Dohme Corporation
$19
Smith+Nephew, Inc.
$17
Ambu Inc.
$17
Ethicon US, LLC
$13
Zyla Life Sciences, Inc.
$12
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Aimovig · CIPRODEX · COMIRNATY · Coblation - Laryngeal Wands · DSUVIA · DUPIXENT · EMGALITY · ENTELLUS - XPRESS ENT DILATION SYSTEM · Endurant · HIRES ULTRA CI HIFOCUS MS ELECTRODE · HiResolution Bionic Ear System · KEYTRUDA · Kerecis Omega3 SurgiClose · LINX Reflux Management System · MED-EL Maestro Cochlear Implant System · NAV - NAV3 NAVIGATION PLATFORM · NUCALA · NURTEC ODT · Nucleus · OXTELLAR XR · Odactra · Otiprio · Otovel · PAXLOVID · QULIPTA · RELIEVA SPINPLUS · RELIEVA SpinPlus NAV Balloon Sinusplasty System · Ryaltris · SPRIX · TAVNEOS · TEPEZZA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TULA System · Tavneos · TruDi NAV Cable · UBRELVY · VIBRANT Soundbridge Middle Ear Implant and BONEBRIDGE System · VOQUEZNA · VYEPTI · XEOMIN · XPRESS ENT DILATION SYSTEM · Xeomin · Xhance · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Otology & neurotology physicians in nearby ZIP areas
5
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Marlowe is a clinical cardiology specialist, with above-average Medicare volume (top 13% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Marlowe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Marlowe performed 1,064 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Marlowe receive payments from pharmaceutical companies?
Yes. Dr. Marlowe received a total of $10,578 from 40 companies across 396 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marlowe's costs compare to other otology & neurotology physicians in Sarasota?
Dr. Marlowe's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marlowe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Otology & Neurotology Physicians in Sarasota
Browse otology & neurotology physicians in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Otology & Neurotology Physicians in FL
Otology & neurotology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Otology & Neurotology Physicians in FL
Which FL otology & neurotology physicians receive the most from drug and device companies.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology